New breast cancer drug cocktail shows 'unprecedented' boost to patient's lifespan

Patients given a cocktail of two drugs by Swiss firm Roche lived 15.7 months longer than those on Herceptin and chemotherapy alone.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news